Bloomberg Intelligence

Eli Lilly to Purchase Morphic, Green Hydrogen

Jul 8, 2024

Sam Fazeli discusses Eli Lilly acquiring Morphic. Sean O'Hara talks about the ETF market. Jared Dillian advises investors. The show covers pharmaceutical acquisitions, market stability, green hydrogen, and investment strategies.

47:04

Creator website

Episode guests

AI Summary

AI Chapters

Episode notes

Podcast summary created with Snipd AI

Quick takeaways

Eli Lilly diversifies into immunology with Morphic acquisition to address inflammatory diseases.

Market insights stress importance of balancing confidence and caution in investments amidst market dynamics.

Deep dives

Current Trends in Trading Platforms by Schwab Trading and Ameritrade

Schwab Trading, now powered by Ameritrade, offers a new comprehensive trading experience tailored for traders, featuring thinkorswim, a powerful award-winning trading platform. Traders can benefit from the support of a dedicated Trade Desk team for trading assistance and access an extensive library of online education resources designed to enhance trading skills, creating a robust trading environment.

Intro

2min

Eli Lilly's Acquisitions and Advancements in Pharma

9min

Discussion on Eli Lilly's Acquisition of Morphic and Drug Pricing in the Pharmaceutical Industry

3min

Navigating Equity Market Concerns and Investment Opportunities

16min

Analysis of the Impact of the Upcoming Election Year on Market Stability and Concentration Risk

2min

Discussion on Pacer ETFs, Thinkorswim Trading Platform, and Cybersecurity by CrowdStrike

2min

Navigating Concentration Risk and Market Uncertainties

8min

Investing at a Young Age and Green Hydrogen

2min

The Rise of Green Hydrogen

5min

10.

Challenges and Solutions in Green Hydrogen Production and Purchase

3min

Watch Bloomberg Intelligence LIVE every day on YouTube: http://bit.ly/3vTiACF.

On today's podcast: Sam Fazeli, Bloomberg Intelligence Director of Research for Global Industries and Senior Pharmaceuticals, on Eli Lilly agreeing to buy Biotech company Morphic. Shelby McFaddin, Investment Analyst at Motley Fool Asset Management. Sean O'Hara, President of Pacer ETFs, on current state of ETFs. Jared Dillian, author and Founder of The Daily Dirtnap, on what investors should be looking out for. And Martin Tengler, Bloomberg BNEF Head of Hydrogen, on US climate goals using clean hydrogen

See omnystudio.com/listener for privacy information.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.

Bloomberg Intelligence

Eli Lilly to Purchase Morphic, Green Hydrogen

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

Deep dives

Current Trends in Trading Platforms by Schwab Trading and Ameritrade

Strategic Acquisition of Morphic by Eli Lilly Expands Immunology Franchise

Pharmaceutical M&A Strategies and Market Insights by Sam Fazelli

Market Analysis and Investment Strategies by Shelby McFadden from Motley Fool Asset Management

Remember Everything You Learn from Podcasts